Highlights
ASX: TLX       TELIX PHARMACEUTICALS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
1.585   +0.02 (1.28%)  1.54 - 1.63  630,273

Overview

 
Avg Volume (4 weeks):1,017,607
4 Weeks Range:1.27 - 1.64
4 Weeks Price Volatility (%):
85.14%
52 Weeks Range:0.54 - 1.775
52 Weeks Price Volatility (%):
84.62%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on development and commercialization of diagnostic and therapeutic products based on radiopharmaceuticals, or molecularly-targeted radiation (MTR). MTR is a novel therapeutic approach that selectively delivers radiation to cells that exhibit certain molecular profiles or targets that may be indicative of cancer. The Company's MTR products such as TLX-250 diagnosis and treatment of renal (kidney), TLX-591 treatment of metastatic castrate-resistant prostate cancer, and TLX-101 treatment of glioblastoma (brain cancer).

  Be the first to like this.
 


 

519  671  625  2558 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GTG 0.006+0.001 
 MEB 0.011-0.002 
 MLX 0.185+0.01 
 SCG 3.85-0.02 
 SIQ 11.25-0.85 
 CL8 0.014+0.005 
 NVO 0.0150.00 
 SRO 0.0020.00 
 88E 0.0140.00 
 AUZ 0.029+0.002 
Partners & Brokers